As of June 30, 2024, the Company held cash and cash equivalents and investment securities of $524.4 million, compared to $617.9 million as of December 31, 2023. Based on the Company’s current operating plan and pending successful completion of the capital preservation measures described above, the Company expects cash, cash equivalents and investment securities will be sufficient to fund operations through the end of 2027.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QURE:
- uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update
- QURE Earnings this Week: How Will it Perform?
- Truist healthcare analyst holds an analyst/industry conference call
- uniQure Advances with Strategic Facility Sale and Partnership Deals
- uniQure announces closing of sale of manufacturing facility to Genezen